| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $54K | — | +103.2% |
| SG&A Expense | $25K | — | -55.9% |
| Operating Income | -$304K | — | +15.3% |
| Interest Expense | $45K | — | -27.3% |
| Pre-tax Income | $2.4M | — | +731.5% |
| Income Tax | $125K | — | — |
| Net Income | $2.2M | — |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $62K | +8.8% | -80.7% |
| Total Assets | $72K | +5.1% | -79.8% |
| Current Liabilities | $5.8M | -34.1% | — |
| Long-term Debt | $2K | -36.7% | — |
| Total Liabilities | $5.8M | -34.1% | -34.8% |
| Stockholders' Equity | -$2.8M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$178K | — | +49.7% |
| Investing Cash Flow | $0 | — | — |
| Financing Cash Flow | $185K | — | — |
| +698.0% |
| EPS (Basic) | $0.00 | — | — |
| EPS (Diluted) | $0.00 | — | — |
| +51.5% |
| +49.8% |